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Csn5, or Csn8 generated from the intact
complex. This indicates that the associa-
tions of these components with the core
of the complex are labile. Interestingly,
despite its peripheral position, Csn5
cannot be reassembled with the DCsn5
7-subunit complex in vitro, but it can be
reassembled with Csn4/6/7 trimer. It
seems that Csn5 can integrate into the
complex only through the step-wise
assembly process. Mouse knockout
studies showed that Csn2, 5, and 8 are
necessary for biogenesis of mammalian
CSN (Lykke-Andersen et al., 2003; To-
moda et al., 2004; Menon et al., 2007).
However the observation that a stable
7-subunit complex can be derived from
the intact complex immediately prompts
the following question: is it possible that
subunits, such as Csn2, Csn5, Csn8, are
important for biogenesis of the CSN, but
once the complex is assembled, these
subunits may leave the complex without
dramatic harm?
If dissociation of a single subunit from
the holocomplex indeed occurs in vivo
rather than amark of instability of a recon-
stituted complex, this finding could open
up many possibilities with regard to func-
tional versatility of the CSN. First, it would
lend further support to the idea that some
of the CSN subunits have independent
functions outside CSN, particularly Csn5
and Csn2, where there is already
compiling evidence (see Wei et al., 2008).
Second, what would be the function of
the 7-subunit CSN that lacks Csn5?
Certainly, it could not be active in dened-
dylation. Unlike mini-CSN subcomplexes,
a 7-subunit CSN complex has not been
reported so far.
The concept that CSN is a modular
assembly is perhaps one of the most
significant conclusions to the mechanism
of the CSN. Not only does it provide an
explanation to many observations of
mini-CSN subcomplexes in the cell, but,
more importantly, it offers a concrete
model based on which the function and
the composition of a particular subcom-
plex can be tested in vivo. With regard to
the specific partitions of the modules
(Csn1/2/3/8 and Csn4/5/6/7), one cannot
help wondering whether theway subcom-
plexes dissociate could be influenced by
how they were reconstituted, as the intact
complex was reconstituted from two sub-
complexes (Csn1/2/3 and Csn4/6/7) and
two individual subunits (Csn5 and Csn8).
Still, the proposed modular model repre-
sents a significant step forward in our
comprehension of the CSN structure. It
will certainly stimulate new hypothesis
and new experiments toward under-
standing how CSN works.
REFERENCES
Cope, G.A., Suh, G.S., Aravind, L., Schwarz, S.E.,
Zipursky, S.L., Koonin, E.V., and Deshaies, R.J.
(2002). Science 298, 608–611.
Dessau, M., Halimi, Y., Erez, T., Chomsky-Hecht,
O., Chamovitz, D.A., and Hirsch, J.A. (2008). The
Plant Cell 20, 2815–2834.
Lykke-Andersen, K., Schaefer, L., Menon, S.,
Deng, X.W., Miller, J.B., and Wei, N. (2003). Mol.
Cell. Biol. 23, 6790–6797.
Menon, S., Chi, H., Zhang, H., Deng, X.-W., Flavell,
R., and Wei, N. (2007). Nat. Immunol. 8, 1236–
1245.
Sharon,M.,Taverner, T.,Ambroggio, X.I.,Deshaies,
R.J., andRobinson, C.V. (2006). PLoSBiol. 4, e267.
Sharon, M., Mao, H., Boeri Erba, E., Stephens, E.,
Zheng, N., and Robinson, C.V. (2009). Structure
17, this issue, 31–40.
Tomoda, K., Yoneda-Kato, N., Fukumoto, A.,
Yamanaka, S., and Kato, J.Y. (2004). J. Biol.
Chem. 279, 43013–43018.
Wei, N., Serino, G., and Deng, X.W. (2008). Trends
Biochem. Sci. 33, 592–600.
Structure
PreviewsJourney to the Ends of the Arf
James M. Gruschus,1 Pei-Wen Chen,2 Ruibai Luo,2 and Paul A. Randazzo2,*
1National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA
2Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892, USA
*Correspondence: randazzp@mail.nih.gov
DOI 10.1016/j.str.2008.12.002
In this issue, Liu et al. (2009) used NMR to provide the most complete information to date on the structure of
Arf1 and the role of myristate in GDP/GTP exchange. Unanticipated details lead to speculation about
functions for the N and C termini of Arfs.Arf GTP-binding proteins are regulators of
membrane traffic and actin remodeling,
and have been recently implicated in the
invasive and metastatic behavior of
cancer cells as well as the metabolism of
growth factor receptors. Arf function
depends on controlled binding and hydro-
lysis of GTP. The association of Arfs with
membranes is also critical to their2 Structure 17, January 14, 2009 ª2009 Elsfunction. Membrane association depends
on a myristoylated N-terminal amphi-
pathic a-helix. Until Liu et al. (2009), all
structural work has used Arf proteins
that lack either the myristate or the myris-
toylated N-terminal helix.
Liu et al. (2009) examine yeast Arf1
(yArf1), which can be prepared in the myr-
istoylated form from bacteria coexpress-evier Ltd All rights reserveding yArf1 and N-myristoyltransferase.
yArf1 is 74% identical to human Arf1.
Consistent with the highly conserved
function of Arf proteins, human Arfs can
rescue arf1arf2 yeast (Kahn et al.,
1991), yArf1 can be used as a substrate
for mammalian Arf GAPs, andmammalian
Arf1 is a substrate for yeast Arf GAPs.
Most or all of what we learn from yArf
Structure
Previewswill likely extrapolate to the human
proteins.
Solving the structure of myristoylated
Arf1 was expected to provide a descrip-
tion of the mechanism for the expulsion
of the myristate from Arf upon GTP
binding. Biochemical results first reported
in early 1990s by Kahn’s lab led to the
model of Arf functioning as a phospho-
lipid- and GTP-dependent switch, and
the prediction that myristate is accommo-
dated within Arf1dGDP but not within
Arf1dGTP. The NMR structure of myris-
toylated yArf1dGDP places the myristoyl
group in a hydrophobic pocket between
a C-terminal helix and a loop connecting
b3 and 4 (l3). Based on the crystal struc-
ture of [D17]ARF1dGTP (Mossessova
et al., 1998), the l3 loop intrudes into
this hydrophobic pocket upon GTP
binding and, consequently, is predicted
to sterically clash with the myristate in
Arf1dGTP.
Another anticipated result was that
myristoylated Arf1 associatesmore tightly
with membranes than nonmyristoylated
Arf1. Kahn and colleagues (1991) first
reported the difference in the binding
affinity of myrArf1 and nonmyr to phos-
pholipids. Liu et al. (2009) found that,
with tighter association, the myristoylated
form of Arf1 has less local motion on the
membrane. This property could increase
association with coat proteins or other
effectors. Other consequences may
include clustering, with lateral organiza-
tion of the membrane and possible
promotion of polymerization of coat
protomers to generate the vesicular
membrane trafficking carriers Arfs are
known to regulate.
Four findings reported by Liu et al.
(2009) were unexpected. The first unan-
ticipated result was related to the struc-
ture and position of the N terminus of
Arf1 (Figure 1). There were fewer detect-
able signals from the first 15 residues of
myristoylated yArf1dGDP than from the
first 15 residues of nonmyristoylated
human Arf1 (Seidel et al., 2004) and there
was broadening of some of the signals
that were detected, indicating a more
plastic, less-defined structure of this
region in myristoylated yArf1, compared
to nonmyristoylated human Arf1. This
difference in the first 15 residues can
explain the difficulty in crystallizing
the myristoylated but not the nonmyris-
toylated Arf1dGDP. In addition toFigure 1. Superposition of Myristoylated Arf1 and Nonmyristoylated Arf2
The N termini and C-terminal helices are highlighted, with the myristoylated Arf1 in yellow and nonmyris-
toylated Arf2 in light green. For myristoylated Arf1, the N-terminal region is flexible and just one member of
the ensemble of possible structures is shown. The myristoyl group is shown in white; note the N-terminal
helix of nonmyristoylated Arf2 occupies the same location as the myristoyl group. The l3 loop is shown in
pink and GDP in orange.affecting the plasticity of the N terminus,
myristate changes the position of the
N terminus. Myristate occupies the hydro-
phobic pocket that was found to be
occupied by the N-terminal a helix in non-
myrArf1dGDP. Assuming that the results
with myristoylated yArf1 will extend to
human Arf1, the plasticity and the position
of themyristoylated N terminus could play
an important biological role, facilitating
contact with proteins such as exchange
factors. Because the N terminus is one
of the most variable regions of the Arf
protein, isoform specific activation could
be achieved. This information about the
plasticity and position of the N terminus
is also relevant to understanding the
molecular basis of Arf activation. The pre-
vailing model for controlled nucleotide
exchange (Pasqualato et al., 2002) was
based on structures of nonmyrArfs and
the position of the N terminus. In the
model, the N terminus acts as a hasp,
stabilizing the GDP form of Arf1. Removal
of the hasp, assisted by the myristate, is
necessary for exchange of GDP for GTP.
Based on Liu and colleagues’ (2009)Structure 17, January 14, 2results, however, the myristate may be
the hasp and the N-terminal 15 amino
acids a handle to pull the hasp. In this
variation of the model (Figure 2), Arf
N terminus/exchange factor interactions
would favor dissociation of the myristate
from the hydrophobic pocket. After disso-
ciation, switches 1 and 2 (see below)
could then adopt the conformations
leading to nucleotide exchange. Consis-
tent with this alternate model, nonmyris-
toylated Arf1, with a more rigid amino
terminus buried in the hydrophobic
pocket, is relatively inert to exchange
factors (Paris et al., 1997). Crystallo-
graphic analyses of Arf1/exchange factor
interactions have used [D17]Arf1 (Renault
et al., 2003; Mossessova et al., 1998),
which lacks the N terminus; conse-
quently, the full extent of N terminus/
exchange factor contact has not yet
been determined.
The second unanticipated result was
that, although it does not make direct
contact, the myristate affects switch 2,
which in turn may affect nucleotide
exchange. The switches lie adjacent to009 ª2009 Elsevier Ltd All rights reserved 3
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Previewsthe nucleotide binding site and are named
for homology with similar nucleotide-
sensitive regions in Ras that mediate
interaction with effectors, guanine nucle-
otide exchange factors, and GTPase-
activating proteins. Compared to nonmyr-
istoylated yArf1, the chemical shifts of
G70, Q71, and Y82 in switch 2 were per-
turbed and the signals for D72-S76 were
lost, indicating greater structural plasticity
for the myristoylated form. The plasticity
may be important for the conformational
changes from the GDP- to GTP-bound
forms of Arf1 and for interaction with
exchange factors. The nonmyristoylated
N terminus, by occupying the hydro-
phobic pocket normally occupied by myr-
istate, may inhibit switch-2 plasticity, and
thus explain the relative insensitivity of
nonmyristoylated Arf to exchange factors.
The third unanticipated result was that
the myristate has extensive contact with
the C-terminal a-helix of Arf1dGDP,
including L170, L173, L177 (see Figures
1 and 2 of Liu et al. [2009]). Consequently,
the C terminus may be exposed when
myristate is expelled when switching
between the GDP- and GTP-bound forms
of Arf. This finding together with the fact
that the N- and C-termini are the most
variable regions of Arf is consistent with
important and specific functional roles of
the C terminus of Arf1 in association with
some target proteins. An example already
reported is the interaction of Arf1dGTP
with PICK1 (Takeya et al., 2000). Myristate
also perturbed the chemical shifts of resi-
dues within the C terminus in Arf1dGDP,
which may be relevant to Arf1 targeting
by cargo proteins (Bremser et al., 1999).
For years the C terminus has been consid-
ered to be inert and was commonly modi-
fied by fusion to both short tags and to
green fluorescent protein and its deriva-
tives. It may be prudent to examine the
functional consequences of the tags
and, if necessary, reinterpret some of
these experiments.
The fourth unanticipated result came
from examining the association of myris-
toylated Arf with lipid bicelles. Myristoy-
lated Arf1dGDP tended to associate
with larger bicelles, presumably more
planar structures, whereas myristoylated
Arf1dGTP associated with bicelles
independently of size. These results are
consistent with the idea that myrArf1
dissociates from curved surfaces
following conversion of myristoylated
Arf1dGTP to myristoylated Arf1dGDP but
are at odds with recently published work
in which myristoylated Arf1dGTP was
found to associate preferentially with
and to induce curved membrane surfaces
(Donaldson, 2008). Arf1, through this
activity, has been proposed to directly
Figure 2. Variation of Hasp Model for Initial Steps in Exchange Factor-Catalyzed Nucleotide
Exchange
In the model, myrArf1dGDP associates with membranes through a highly plastic N terminus, which also
covers the myristate in a hydrophobic pocket in the protein. The myristate acts as a hasp, preventing
molecular rearrangements that accompany nucleotide exchange. An exchange factor makes contact
with the N-terminal helix, using it as a handle to pull the myristate from the hydrophobic pocket. This event
initiates protein rearrangements, including the movement of loop l3 into the hydrophobic pocket, and
association of switch 2 with the exchange factor, which is necessary for GDP dissociation.4 Structure 17, January 14, 2009 ª2009 Elsevier Ltd All rights reserveddeform the lipid bilayer necessary for
transport vesicle formation. Reconciling
these results will be important for under-
standing the molecular contribution of
Arf to the generation of vesicle transport
intermediates.
The unexpected findings highlight that,
24 years after Arf was discovered (Kahn
and Gilman, 1984), the molecular basis
of Arf function is still not understood. A
full description of Arf action will depend
on continuing structural and quantitative
studies exemplified by the work reported
by Liu et al.
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